Hospital Sirio Libanes

Brasília, Federal District 70200-730

2 studies enrolling now · 4 studies all time

What they study most

Advanced Renal Cell Carcinoma (RCC), Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Locally Advanced Metastatic NSCLC, Locally Advanced Unresectable NSCLC, Metastatic Castration-Resistant Prostate Cancer, Non Small-cell Lung Cancer

Studies at this site

• A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) — Recruiting now
• A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. — Recruiting now
• Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. — Stopped early
• Expanded Access of Sotorasib — NO_LONGER_AVAILABLE